177 related articles for article (PubMed ID: 38535623)
1. A Multiomics Assessment of Preoperative Exercise in Pancreatic Cancer Survivors Receiving Neoadjuvant Therapy: A Case Series.
Nemkov T; Cendali F; Dzieciatkowska M; Stephenson D; Hansen KC; Jankowski CM; D'Alessandro A; Marker RJ
Pathophysiology; 2024 Mar; 31(1):166-182. PubMed ID: 38535623
[TBL] [Abstract][Full Text] [Related]
2. Feasibility and Preliminary Efficacy of a 10-Week Resistance and Aerobic Exercise Intervention During Neoadjuvant Chemoradiation Treatment in Rectal Cancer Patients.
Singh F; Galvão DA; Newton RU; Spry NA; Baker MK; Taaffe DR
Integr Cancer Ther; 2018 Sep; 17(3):952-959. PubMed ID: 29888608
[TBL] [Abstract][Full Text] [Related]
3. Improvements in strength and agility measures of functional fitness following a telehealth-delivered home-based exercise intervention in endometrial cancer survivors.
Gorzelitz JS; Stoller S; Costanzo E; Gangnon R; Koltyn K; Dietz AT; Spencer RJ; Rash J; Cadmus-Bertram L
Support Care Cancer; 2022 Jan; 30(1):447-455. PubMed ID: 34304292
[TBL] [Abstract][Full Text] [Related]
4. Moderators of resistance-based exercise programs' effect on sarcopenia-related measures in men with prostate cancer previously or currently undergoing androgen deprivation therapy: An individual patient data meta-analysis.
Lopez P; Newton RU; Taaffe DR; Winters-Stone K; Galvão DA; Buffart LM
J Geriatr Oncol; 2023 Jun; 14(5):101535. PubMed ID: 37229882
[TBL] [Abstract][Full Text] [Related]
5. Critical issues in pathologic evaluation of pancreatic ductal adenocarcinoma resected after neoadjuvant treatment: a narrative review.
Taherian M; Wang H
Chin Clin Oncol; 2022 Jun; 11(3):21. PubMed ID: 35726190
[TBL] [Abstract][Full Text] [Related]
6. Blood-Based Multiomics-Guided Detection of a Precancerous Pancreatic Tumor.
Anwar MA; Keshteli AH; Yang H; Wang W; Li X; Messier HM; Cullis PR; Borchers CH; Fraser R; Wishart DS
OMICS; 2024 Apr; 28(4):182-192. PubMed ID: 38634790
[TBL] [Abstract][Full Text] [Related]
7. Home-Based Exercise Prehabilitation During Preoperative Treatment for Pancreatic Cancer Is Associated With Improvement in Physical Function and Quality of Life.
Ngo-Huang A; Parker NH; Bruera E; Lee RE; Simpson R; O'Connor DP; Petzel MQB; Fontillas RC; Schadler K; Xiao L; Wang X; Fogelman D; Sahai SK; Lee JE; Basen-Engquist K; Katz MHG
Integr Cancer Ther; 2019; 18():1534735419894061. PubMed ID: 31858837
[No Abstract] [Full Text] [Related]
8. Erratum.
Mult Scler; 2016 Oct; 22(12):NP9-NP11. PubMed ID: 26041800
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant therapy for pancreatic ductal adenocarcinoma: Opportunities for personalized cancer care.
Hamad A; Brown ZJ; Ejaz AM; Dillhoff M; Cloyd JM
World J Gastroenterol; 2021 Jul; 27(27):4383-4394. PubMed ID: 34366611
[TBL] [Abstract][Full Text] [Related]
10. Role of imaging in evaluating the response after neoadjuvant treatment for pancreatic ductal adenocarcinoma.
Zhang Y; Huang ZX; Song B
World J Gastroenterol; 2021 Jun; 27(22):3037-3049. PubMed ID: 34168406
[TBL] [Abstract][Full Text] [Related]
11. Defining the Optimal Duration of Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma: Time for a Personalized Approach?
Puleo A; Malla M; Boone BA
Pancreas; 2022 Oct; 51(9):1083-1091. PubMed ID: 37078929
[TBL] [Abstract][Full Text] [Related]
12. Risk Stratification of Pancreatic Ductal Adenocarcinoma Patients Undergoing Curative-Intent Surgery after Neoadjuvant Therapy.
Yang HK; Park MS; Han K; Eom G; Chung YE; Choi JY; Bang S; Kang CM; Seong J; Kim MJ
Cancer Res Treat; 2024 Jan; 56(1):247-258. PubMed ID: 37605535
[TBL] [Abstract][Full Text] [Related]
13. Physical exercise training interventions for children and young adults during and after treatment for childhood cancer.
Braam KI; van der Torre P; Takken T; Veening MA; van Dulmen-den Broeder E; Kaspers GJ
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD008796. PubMed ID: 27030386
[TBL] [Abstract][Full Text] [Related]
14. Supervised resistance exercise for women with ovarian cancer who have completed first-line treatment: a pragmatic study.
Schofield C; Newton RU; Taaffe DR; Galvão DA; Cohen PA; Meniawy TM; Peddle-McIntyre CJ
Support Care Cancer; 2023 Apr; 31(5):304. PubMed ID: 37101013
[TBL] [Abstract][Full Text] [Related]
15. Feasibility and efficacy of a multicomponent exercise medicine programme in patients with pancreatic cancer undergoing neoadjuvant therapy (the EXPAN trial): study protocol of a dual-centre, two-armed phase I randomised controlled trial.
Luo H; Galvão DA; Newton RU; Tang C; Dean A; Jasas K; Johansson M; Yusoff I; Spry N; Taaffe DR
BMJ Open Gastroenterol; 2021 Jun; 8(1):. PubMed ID: 34099463
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant chemotherapy is associated with an altered metabolic profile and increased cancer stemness in patients with pancreatic ductal adenocarcinoma.
Amrutkar M; Verbeke CS; Finstadsveen AV; Dorg L; Labori KJ; Gladhaug IP
Mol Oncol; 2023 Jan; 17(1):59-81. PubMed ID: 36400567
[TBL] [Abstract][Full Text] [Related]
17. Home-based exercise during preoperative therapy for pancreatic cancer.
Ngo-Huang A; Parker NH; Wang X; Petzel MQB; Fogelman D; Schadler KL; Bruera E; Fleming JB; Lee JE; Katz MHG
Langenbecks Arch Surg; 2017 Dec; 402(8):1175-1185. PubMed ID: 28710540
[TBL] [Abstract][Full Text] [Related]
18. A multicentre year-long randomised controlled trial of exercise training targeting physical functioning in men with prostate cancer previously treated with androgen suppression and radiation from TROG 03.04 RADAR.
Galvão DA; Spry N; Denham J; Taaffe DR; Cormie P; Joseph D; Lamb DS; Chambers SK; Newton RU
Eur Urol; 2014 May; 65(5):856-64. PubMed ID: 24113319
[TBL] [Abstract][Full Text] [Related]
19. Impact of Neoadjuvant Therapy in Resected Pancreatic Ductal Adenocarcinoma of the Pancreatic Body or Tail on Surgical and Oncological Outcome: A Propensity-Score Matched Multicenter Study.
Lof S; Korrel M; van Hilst J; Alseidi A; Balzano G; Boggi U; Butturini G; Casadei R; Dokmak S; Edwin B; Falconi M; Keck T; Malleo G; de Pastena M; Tomazic A; Wilmink H; Zerbi A; Besselink MG; Abu Hilal M;
Ann Surg Oncol; 2020 Jun; 27(6):1986-1996. PubMed ID: 31848815
[TBL] [Abstract][Full Text] [Related]
20. Gemcitabine-Based Neoadjuvant Treatment in Borderline Resectable Pancreatic Ductal Adenocarcinoma: A Meta-Analysis of Individual Patient Data.
Giovinazzo F; Soggiu F; Jang JY; Versteijne E; van Tienhoven G; van Eijck CH; Han Y; Choi SH; Kang CM; Zalupski M; Ahmad H; Yentz S; Helton S; Rose JB; Takishita C; Nagakawa Y; Abu Hilal M
Front Oncol; 2020; 10():1112. PubMed ID: 32850319
[No Abstract] [Full Text] [Related]
[Next] [New Search]
